Get started
Author

Tim W. Failes

Observed names: T. Failes, T.W Failes, Tim Failes
ORCID: 0000-0003-4618-1057
Observed ORCID: 0000-0003-4618-1057
OpenAlex ID: A5000436219
Pilot study of a comprehensive precision medicine platform for children with high-risk cancer.
2017 · Loretta Lau, Jennifer Byrne, et al. · Journal of Clinical Oncology · 10
Reverse molecular pharmacology identifies the non-canonical axis of IRAK as a chemoresistance factor in neuroblastoma
2026 · M Le Grand, C Buxbaum, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Abstract 3111: Zero Childhood Cancer: A comprehensive precision medicine platform for children with high-risk cancer
2019 · Emily V. Mould, Loretta Lau, et al. · Cancer Research · 1
Abstract LB-137: Integrated genomics: drug screening and personalized xenograft development approach to identify precision treatments for aggressive pediatric brain tumors
2018 · Maria Tsoli, Carol Wadham, et al. · Cancer Research · 1
Zero childhood cancer – Accelerating translation of experimental oncology: Better matching drug to target
2018 · Vanessa Tyrrell, Loretta Lau, et al. · Pathology · 1
Synergistic action of first-in-class anti-tropomyosin compound, ATM-3507 (Anisina) and microtubule targeting inhibitors in pre-clinical models of non-small cell lung cancer (NSCLC)
2016 · J. Stehn, A. Mariana, et al. · European Journal of Cancer · 1
Abstract 3660: Discovery of a small molecule TUBB3/βIII-tubulin modulator in lung cancer
2015 · Felicity Chao Lin Kao, Tim Failes, et al. · Cancer Research · 1
Clinical Response to Azacytidine (AZA) Is Associated with Increased Contribution from Mutated Blood Progenitors: Insights from Single Cell Genotyping of Matched Stem/Progenitor and Mature Blood Cells from MDS/CMML Patients Pre- and Post-AZA Treatment
2022 · Julie A.I. Thoms, Annatina Schnegg-Kaufmann, et al. · Blood
Ddel-12. Nanoparticle Delivery of Doxorubicin for the Treatment of Diffuse Intrinsic Pontine Glioma (dipg)
2020 · Caitlin Ung, Maria Tsoli, et al. · Neuro-Oncology
PDF
Dipg-75. Precision Medicine for Paediatric High-grade Diffuse Midline Gliomas - Results From the Zero Childhood Cancer Comprehensive Precision Medicine Program
2020 · Dong-Anh Khuong-Quang, Sumanth Nagabushan, et al. · Neuro-Oncology
PDF
Abstract IA13: Molecular targeted therapies and precision medicine for children with neuroblastoma and other refractory malignancies
2020 · Michelle Haber, Laura Gamble, et al. · Cancer Research
Molecular targeted therapies and precision medicine for children with neuroblastoma and other refractory malignancies
2020 · Michelle Haber, Laura D. Gamble, et al. · Cancer Research
Abstract 3111: Zero Childhood Cancer: A comprehensive precision medicine platform for children with high-risk cancer
2019 · Emily V. Mould, Loretta Lau, et al. · Clinical Research (Excluding Clinical Trials)
Ther-23. Results of the Zero Childhood Cancer Integrated Precision Medicine Platform for Paediatric High-risk Brain Tumours
2019 · Maria Tsoli, Loretta Lau, et al. · Neuro-Oncology
Abstract LB-138: Zero Childhood Cancer: A comprehensive precision medicine platform for children with high-risk cancer
2018 · Emily Mould, Loretta Lau, et al. · Cancer Research
PO-405 Repositioning existing drugs as novel therapeutics for high-risk paediatric leukaemia
2018 · M. Karsa, T. Failes, et al. · ESMO Open
Abstract 4037: High throughput kinase inhibitor screen reveals novel inhibitor combinations acting in synergy with TUBB3/βIII-tubulin suppression in non-small cell lung cancer
2017 · Wee Siang Teo, Tanya Dwarte, et al. · Cancer Research
Abstract B23: Selective and rapid killing of mixed lineage leukemia and CALM-AF10 leukemia by SM7, a novel small molecule identified by chemical library screening
2016 · Daria Chudakova, Klaartje Somers, et al. · Cancer Research
Abstract 4550: High throughput screen to identify compounds that reverse glucocorticoid resistance in pediatric leukemia.
2013 · Cara Toscan, Tim Failes, et al. · Cancer Research
ACRF Drug Discovery Centre for Childhood Cancer: servicing cancer drug discovery
2012 · Greg M. Arndt, Tim Failes, et al. · F1000Research
Works count: 20
Citation count: 16
H-index: 1
I10-index: 1
Year
Topic
Type